You need to enable JavaScript to run this app.
FDA proposes to modernize guidance on sex, gender in clinical trials
Regulatory News
Emily Hayes
Biologics/ biosimilars/ vaccines
Clinical Trials
Guidance
Medical Devices
Pharmaceuticals
United States
US Food and Drug Administration (FDA)